Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Santen Pharmaceutical Co Ltd (SNPHF)
OTHER OTC:SNPHF
RESEARCH TOOLSreports
Holding SNPHF?
Track your performance easily
SNPHF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.50 - $14.98
Previous Close$10.77
Volume64.00
Average Volume (3M)759.00
Market Cap
$3.92B
Enterprise Value$3.52B
Total Cash (Recent Filing)¥62.32B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)22.1
Beta-0.07
Next Earnings
Feb 06, 2025EPS Estimate
$0.16Next Dividend Ex-Date
Mar 28, 2025Dividend Yield2.12%
Share Statistics
EPS (TTM)0.49
Shares OutstandingN/A
10 Day Avg. Volume202
30 Day Avg. Volume759
Standard Deviation0.08
R-Squared0.04
Alpha-0.00433
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.60
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Santen Pharmaceutical Co News
PremiumCompany Announcements
Santen Pharmaceutical Co. Reports Mixed Financial Results
PremiumCompany Announcements
Santen Completes Strategic Share BuybackPremiumCompany Announcements
Santen Pharmaceutical Cancels Significant Treasury Shares
PremiumCompany Announcements
Santen Pharmaceutical Announces Share Buyback Plan
PremiumCompany Announcements
Santen’s Share Buyback Progress Update
PremiumCompany Announcements
Santen Pharmaceutical Executes Share Buyback
PremiumCompany Announcements
Santen Pharma Completes Key Stock Remuneration PlanOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
7.08% Mutual Funds
― Other Institutional Investors
87.43% Public Companies and
Individual Investors
SNPHF FAQ
What was Santen Pharmaceutical Co Ltd’s price range in the past 12 months?
Santen Pharmaceutical Co Ltd lowest stock price was $8.50 and its highest was $14.98 in the past 12 months.
What is Santen Pharmaceutical Co Ltd’s market cap?
Currently, no data Available
When is Santen Pharmaceutical Co Ltd’s upcoming earnings report date?
Santen Pharmaceutical Co Ltd’s upcoming earnings report date is Feb 06, 2025 which is in 71 days.
How were Santen Pharmaceutical Co Ltd’s earnings last quarter?
Santen Pharmaceutical Co Ltd released its earnings results on Nov 07, 2024. The company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.01.
Is Santen Pharmaceutical Co Ltd overvalued?
According to Wall Street analysts Santen Pharmaceutical Co Ltd’s price is currently Overvalued.
Does Santen Pharmaceutical Co Ltd pay dividends?
Santen Pharmaceutical Co Ltd pays a Annually dividend of $0.11 which represents an annual dividend yield of 2.12%. See more information on Santen Pharmaceutical Co Ltd dividends here
What is Santen Pharmaceutical Co Ltd’s EPS estimate?
Santen Pharmaceutical Co Ltd’s EPS estimate is $0.16.
How many shares outstanding does Santen Pharmaceutical Co Ltd have?
Santen Pharmaceutical Co Ltd has 364,022,250 shares outstanding.
What happened to Santen Pharmaceutical Co Ltd’s price movement after its last earnings report?
Santen Pharmaceutical Co Ltd reported an EPS of $0.15 in its last earnings report, beating expectations of $0.14. Following the earnings report the stock price went down -0.345%.
Which hedge fund is a major shareholder of Santen Pharmaceutical Co Ltd?
Currently, no hedge funds are holding shares in SNPHF
---
Santen Pharmaceutical Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.61%
12-Months-Change
Fundamentals
Return on Equity
8.46%
Trailing 12-Months
Asset Growth
-0.05%
Trailing 12-Months
Company Description
Santen Pharmaceutical Co Ltd
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Other segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
---
SNPHF Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SNPHF
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-6.90%
reiterated a buy rating 4 months ago
Copying Seiji Wakao's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -6.90% per trade.
---